ArticleVaccines2022
Shoulder Injury Related to COVID-19 Vaccine Administration: A Case Series.
Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.
- Pooled it
- Individualized Deltoid Landmark and Needle Length for Safe Intramuscular Vaccination in Southeast Asian Adults: An Ultrasound Study.Life (Basel, Switzerland) · 2026Article
- Bilateral Myositis Ossificans of the Deltoid Muscle Secondary to the COVID-19 Vaccine: A Case Report.Case reports in medicine · 2026Article
- Review
- Alleviation of shoulder injury related to vaccine administration (SIRVA) pain and disability following COVID-19 vaccine with chiropractic biophysicsJournal of physical therapy science · 2023Article
- Analysis of patients with adhesive capsulitis after COVID-19 vaccination: An observational study.Turkish journal of physical medicine and rehabilitation · 2023Article
- Chronic stage magnetic resonance imaging findings in patients with shoulder injury related to vaccine administration (SIRVA).Skeletal radiology · 2023Article
- Establishment of prediction equations for subcutaneous tissue thickness in two representative intramuscular deltoid injections.Vaccine: X · 2023Article
- Acute myopericarditis and left shoulder capsulitis following second dose of mRNA SARS-CoV-2 Moderna vaccination.BMJ case reports · 2023Article
- Partial infraspinatus tear with bursitis following an mRNA vaccination: a case report.Annals of medicine and surgery (2012) · 2023Article
- Safety of COVID-19 vaccine delivery by dentists: An observational cohort study.Journal of dental sciences · 2023Article
- Appropriate intradeltoid muscle needle penetration depth in vaccine administration: an MRI study in Thailand.Frontiers in immunology · 2023Article
- Septic arthritis of shoulder joint following a COVID-19 vaccination: A case report.International journal of surgery case reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA shoulder injury related to vaccine administration (SIRVA) is a vaccination complication that can affect daily life activities. To date, there have been no case series of patients diagnosed as SIRVA following a COVID-19 vaccination. We offer a series of seven SIRVA cases including clinical presentations, investigations and treatment outcomes.
methodsA retrospective chart review was performed for seven patients who developed SIRVA following a COVID-19 vaccination between April 2021 and October 2021. All patients had no prior shoulder pain before their vaccination and then developed shoulder pain within a few days following the vaccination, which did not spontaneously improve within 1 week.
resultsFour of the seven patients were male, and the average age was 62.29 ± 7.76 years. The average body mass index was 25.1 ± 2.2 kg/m DISCUSSION AND
conclusionIn our series, the most common cause of SIRVA was an incorrect vaccination technique. Most patients responded well to oral NSAIDs or oral prednisolone. CLINICAL RELEVANCE: All SIRVAs were from an incorrect injection technique and not actually the vaccination, so our series highlights the importance of ensuring all vaccinators understand the importance of taking proper care with the injection technique. Additionally, most of our patients with SIRVA from a COVID-19 injection responded well to oral prednisolone (30 mg/day). If there are no contraindications, we suggest this as the first line treatment for COVID-19-related SIRVA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.